NuvOx Therapeutics
As seen on the 24/7 Wall St. homepage on July 17, 2026.
NuvOx Therapeutics
NUOX · NYSE American
$6–$8 / share
$20M raise
2,860,000 shares
Oxygen therapeutics biotech NuvOx filed for a $20 million IPO on NYSE American, pricing 2.86 million shares at $6 to $8 each as it advances its platform for treating hypoxia and tissue damage.
Mentioned: NUOX